OBJECTIVES: Within the Alzheimer's Disease Neuroimaging Initiative (ADNI)'s mild cognitive impairment (MCI) cohort, we previously identified MCI subtypes as well as participants initially diagnosed with MCI but found to have normal neuropsychological, biomarker, and neuroimaging profiles. We investigated the functional change over time in these empirically derived MCI subgroups. METHODS: ADNI MCI participants (n=654) were classified using cluster analysis as Amnestic MCI (single-domain memory impairment), Dysnomic MCI (memory+language impairments), Dysexecutive/Mixed MCI (memory+language+attention/executive impairments), or Cluster-Derived Normal (CDN). Robust normal control participants (NCs; n=284) were also examined. The Functional Activities Questionnaire (FAQ) was administered at baseline through 48-month follow-up. Multilevel modeling examined FAQ trajectories by cognitive subgroup. RESULTS: The Dysexecutive/Mixed group demonstrated the fastest rate of decline across all groups. Amnestic and Dysnomic groups showed steeper rates of decline than CDNs. While CDNs had more functional difficulty than NCs across visits, both groups' mean FAQ scores remained below its suggested cutoff at all visits. CONCLUSIONS: Results (a) show the importance of executive dysfunction in the context of other impaired cognitive domains when predicting functional decline in at-risk elders, and (b) support our previous work demonstrating that ADNI's MCI criteria may have resulted in false-positive MCI diagnoses, given the CDN's better FAQ trajectory than those of the cognitively impaired MCI groups. (JINS, 2017, 23, 521-527).
OBJECTIVES: Within the Alzheimer's Disease Neuroimaging Initiative (ADNI)'s mild cognitive impairment (MCI) cohort, we previously identified MCI subtypes as well as participants initially diagnosed with MCI but found to have normal neuropsychological, biomarker, and neuroimaging profiles. We investigated the functional change over time in these empirically derived MCI subgroups. METHODS:ADNI MCI participants (n=654) were classified using cluster analysis as Amnestic MCI (single-domain memory impairment), Dysnomic MCI (memory+language impairments), Dysexecutive/Mixed MCI (memory+language+attention/executive impairments), or Cluster-Derived Normal (CDN). Robust normal control participants (NCs; n=284) were also examined. The Functional Activities Questionnaire (FAQ) was administered at baseline through 48-month follow-up. Multilevel modeling examined FAQ trajectories by cognitive subgroup. RESULTS: The Dysexecutive/Mixed group demonstrated the fastest rate of decline across all groups. Amnestic and Dysnomic groups showed steeper rates of decline than CDNs. While CDNs had more functional difficulty than NCs across visits, both groups' mean FAQ scores remained below its suggested cutoff at all visits. CONCLUSIONS: Results (a) show the importance of executive dysfunction in the context of other impaired cognitive domains when predicting functional decline in at-risk elders, and (b) support our previous work demonstrating that ADNI's MCI criteria may have resulted in false-positive MCI diagnoses, given the CDN's better FAQ trajectory than those of the cognitively impaired MCI groups. (JINS, 2017, 23, 521-527).
Authors: Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi Journal: Alzheimers Dement Date: 2014-05-22 Impact factor: 21.566
Authors: Virginia G Wadley; Michael Crowe; Michael Marsiske; Sarah E Cook; Frederick W Unverzagt; Adrienne L Rosenberg; Daniel Rexroth Journal: J Am Geriatr Soc Date: 2007-08 Impact factor: 5.562
Authors: Katherine J Bangen; Alexandra L Clark; Madeline Werhane; Emily C Edmonds; Daniel A Nation; Nicole Evangelista; David J Libon; Mark W Bondi; Lisa Delano-Wood Journal: J Alzheimers Dis Date: 2016-03-29 Impact factor: 4.472
Authors: Emily C Edmonds; Joel Eppig; Mark W Bondi; Kelly M Leyden; Bailey Goodwin; Lisa Delano-Wood; Carrie R McDonald Journal: Neurology Date: 2016-10-19 Impact factor: 9.910
Authors: Emily C Edmonds; Alexandra J Weigand; Kelsey R Thomas; Joel Eppig; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi Journal: J Int Neuropsychol Soc Date: 2018-09 Impact factor: 2.892
Authors: Emily C Edmonds; Carrie R McDonald; Anisa Marshall; Kelsey R Thomas; Joel Eppig; Alexandra J Weigand; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi Journal: Alzheimers Dement Date: 2019-02-06 Impact factor: 21.566
Authors: Sheina Emrani; David J Libon; Melissa Lamar; Catherine C Price; Angela L Jefferson; Katherine A Gifford; Timothy J Hohman; Daniel A Nation; Lisa Delano-Wood; Amy Jak; Katherine J Bangen; Mark W Bondi; Adam M Brickman; Jennifer Manly; Rodney Swenson; Rhoda Au Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Kelsey R Thomas; Joel S Eppig; Alexandra J Weigand; Emily C Edmonds; Christina G Wong; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi Journal: Alzheimers Dement Date: 2019-01-11 Impact factor: 21.566
Authors: Kelsey R Thomas; Jessica R Osuna; Alexandra J Weigand; Emily C Edmonds; Alexandra L Clark; Sophia Holmqvist; Isabel H Cota; Christina E Wierenga; Mark W Bondi; Katherine J Bangen Journal: J Cereb Blood Flow Metab Date: 2020-07-02 Impact factor: 6.200
Authors: Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Erin Sundermann; Christina G Wong; Joel Eppig; Madeleine L Werhane; Lisa Delano-Wood; Mark W Bondi Journal: Alzheimer Dis Assoc Disord Date: 2020 Jan-Mar Impact factor: 2.703
Authors: Kelsey R Thomas; Emily C Edmonds; Joel S Eppig; Christina G Wong; Alexandra J Weigand; Katherine J Bangen; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi Journal: Alzheimers Dement Date: 2019-09-05 Impact factor: 21.566
Authors: Katherine J Bangen; Kelsey R Thomas; Alexandra J Weigand; Danielle L Sanchez; Lisa Delano-Wood; Emily C Edmonds; Owen T Carmichael; Christopher G Schwarz; Adam M Brickman; Mark W Bondi Journal: Neurobiol Aging Date: 2019-11-02 Impact factor: 4.673
Authors: Alyssa N De Vito; Matthew Calamia; Daniel S Weitzner; John P K Bernstein Journal: Int J Geriatr Psychiatry Date: 2018-10-01 Impact factor: 3.485
Authors: Emily C Edmonds; Alexandra J Weigand; Sean N Hatton; Anisa J Marshall; Kelsey R Thomas; Daniela A Ayala; Mark W Bondi; Carrie R McDonald Journal: Neurology Date: 2020-05-11 Impact factor: 9.910